Inovio pharmaceuticals stock.
The consensus among analysts is that Inovio Pharmaceuticals Inc (INO) is a Hold stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 3 out of 3 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight.
It seems like a long time ago that Inovio Pharmaceuticals ... Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002.WebThe latest closing stock price for Inovio Pharmaceuticals as of November 17, 2023 is 0.43. The all-time high Inovio Pharmaceuticals stock closing price was 191.04 on March 03, 2000. The Inovio Pharmaceuticals 52-week high stock price is 2.17, which is 404.7% above the current share price. The Inovio Pharmaceuticals 52-week low stock price is …The proposed Settlement will create a cash settlement fund of $30,000,000 in cash and 7,000,000 shares of Inovio common stock (the "Settlement Stock") to be ...According to the issued ratings of 1 analysts in the last year, the consensus rating for Inovio Pharmaceuticals stock is Hold based on the current 1 hold rating for INO. The average twelve-month price prediction for Inovio Pharmaceuticals is $2.00 with a high price target of $2.00 and a low price target of $2.00.Nov 8, 2022 · As of September 30, 2022, INOVIO had 249.5 million common shares outstanding and 268.7 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. INOVIO reported ...
Plymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) - INOVIO (NASDAQ:INO) has released the following pursuant to an order of the UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA: UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA IN RE INOVIO PHARMACEUTICALS, INC. DERIVATIVE LITIGATION Lead Case No. 2:20-cv-01962-GJP NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF ...
A class-action lawsuit claims that pharmaceutical company Inovio deceived the public about developing a COVID-19 vaccine, leading its stock to rise and then crash. Patrick McDermid v. Inovio Pharmaceuticals Inc. et al. Plaintiffs submitted a motion to certify the class action on Thursday, claiming thousands of investors were affected.
Inovio Pharmaceuticals Inc INO Morningstar Rating Unlock Stock XNAS Rating as of Nov 30, 2023 Summary Chart News Price vs Fair Value Sustainability …Get a real-time Inovio Pharmaceuticals, Inc. (INO) stock price quote with breaking news, financials, statistics, charts and more.Please complete this form relating to your transactions for Inovio Pharmaceuticals, Inc. (Nasdaq: INO) common stock between February 14, 2020 and March 9, ...Data delayed at least 15 minutes, as of Nov 17 2023 07:01 GMT. More ▽. Find ...INO | Complete Inovio Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
1 Mei 2020 ... Inovio Pharmaceuticals' stock has climbed higher and higher over the past month since it said it was working on a speedy COVID-19 vaccine.
Sep. 7, 2023, 08:14 AM. (RTTNews) - Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy ...Web
Nov 28, 2023 · 52-week High/Low: $2.07 / $0.32. 50/200 Day Moving Average: $0.407 / $0.664. This figure corresponds to the Average Price over the previous 50/200 days. For Inovio Pharmaceuticals stocks, the 50-day moving average is the support level today. For Inovio Pharmaceuticals stocks, the 200-day moving average is the resistance level today. The stock price for . Inovio Pharmaceuticals (NASDAQ: INO) is $0.4205 last updated Today at November 28, 2023 at 12:50 AM UTC. Q Does Inovio Pharmaceuticals (INO) pay a dividend?Nov 8, 2022 · As of September 30, 2022, INOVIO had 249.5 million common shares outstanding and 268.7 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. INOVIO reported ... Nasdaq 14,295.90 +0.39% +54.88 Russell 1,801.91 +0.042% +0.76 VIX 12.68 -0.079% -0.0100 Home INO • NASDAQ Inovio Pharmaceuticals Inc Follow Share $0.40 Nov 28, 11:47:07 AM GMT-5 · USD ·...Three months after bringing on a new CEO, Inovio has reached a settlement with investors over accusations that it exaggerated progress on its Covid-19 vaccine candidate. The biotech, once claiming ...Web
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 9 at 9:04 PM: Inovio Pharmaceuticals cuts 30% of staff in third round of layoffs in 13 months bizjournals.com - August 1 at 7:38 PM: Inovio Pharmaceuticals (INO) Stock Up, Begins Recruitment for MERS Vaccine Trial thestreet.com - July 28 at 8:03 AMSee Inovio Pharmaceuticals, Inc. (INO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Nov 8, 2022 · As of September 30, 2022, INOVIO had 249.5 million common shares outstanding and 268.7 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. INOVIO reported ... See Inovio Pharmaceuticals, Inc. (INO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.PLYMOUTH MEETING, Pa., July 26, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that second quarter 2023 financial results will be …
Research & Development Center. 10480 Wateridge Circle San Diego, CA 92121 Phone: 858-597-6006Inovio Pharmaceuticals. Market Cap. $111M. Today's Change. (2.77%) $0.01. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ...
Find the latest Inovio Pharmaceuticals, Inc. (INO.MX) stock quote, history, news and other vital information to help you with your stock trading and investing.WebThe proposed Settlement will create a cash settlement fund of $30,000,000 in cash and 7,000,000 shares of Inovio common stock (the "Settlement Stock") to be ...About the Inovio Pharmaceuticals, Inc. stock forecast. As of 2023 November 29, Wednesday current price of INO stock is 0.400$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Inovio Pharmaceuticals stock price has been showing a declining tendency so we believe that …Find the latest Inovio Pharmaceuticals, Inc. (INO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.At INOVIO, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section. If you experience any issues with this process, please contact us for further assistance.INO stock trades near $10 currently and it is, in fact, down 27% from its pre-Covid high of around $14 in early March 2020 – before the coronavirus pandemic hit the world. INO stock has had a ...Web4 Mar 2020 ... Shares of Inovio Pharmaceuticals Inc., the genetic vaccine company, hit a four-year high Wednesday, rising as much as 16% to $9.40 a share ...4 Mar 2020 ... Shares of Inovio Pharmaceuticals Inc., the genetic vaccine company, hit a four-year high Wednesday, rising as much as 16% to $9.40 a share ...Inovio Pharmaceuticals stock has received a consensus rating of hold. The average rating score is and is based on 0 buy ratings, 5 hold ratings, and 1 sell ratings. What was the 52-week low for ...
Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing. Home. ... Q3 2023 Earnings Call Transcript November 9, 2023 Inovio Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS, expectations were $-0.13 ...
The latest closing stock price for Inovio Pharmaceuticals as of November 17, 2023 is 0.43. The all-time high Inovio Pharmaceuticals stock closing price was 191.04 on March 03, 2000. The Inovio Pharmaceuticals 52-week high stock price is 2.17, which is 404.7% above the current share price. The Inovio Pharmaceuticals 52-week low stock price is …
plymouth meeting, pa., june 23, 2023 (globe newswire) - inovio (nasdaq:ino) has released the following pursuant to an order of the united states district court eastern district of pennsylvania: united states district court eastern district of pennsylvania in re inovio pharmaceuticals, inc. derivative litigation lead case no. 2:20-cv-01962-gjp notice of …Inovio Pharmaceuticals. Market Cap. $137M. Today's Change. (-3.25%) -$0.02. Current Price. $0.51. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...WebFind out the direct holders, institutional holders and mutual fund holders for Inovio Pharmaceuticals, Inc. (INO).Inovio Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time INO stock price.ROBERT J. JUBA JR. “INOVIO’s team has extensive experience manufacturing DNA medicines and a proven track record of producing them at unprecedented speeds.”. “INOVIO’s CELLECTRA® intramuscular and intracellular smart devices have allowed us to deliver our optimized DNA plasmids directly into cells in the body to produce immune responses. INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-19 vaccines INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA …Webto: all record holders and beneficial owners of inovio pharmaceuticals, inc. (“INOVIO” OR THE “COMPANY”) COMMON STOCK AS OF MARCH 31, 2023. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ...WebAug 26, 2022 · Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38. It opened Friday at $2.51 per share. About the Inovio Pharmaceuticals, Inc. stock forecast. As of 2023 November 29, Wednesday current price of INO stock is 0.400$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Inovio Pharmaceuticals stock price has been showing a declining tendency so we believe that …
Plymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) - INOVIO (NASDAQ:INO) has released the following pursuant to an order of the UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA: UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA IN RE INOVIO PHARMACEUTICALS, INC. DERIVATIVE LITIGATION Lead Case No. 2:20-cv-01962-GJP NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF ...Research Inovio Pharmaceuticals' (Nasdaq:INO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...ROBERT J. JUBA JR. “INOVIO’s team has extensive experience manufacturing DNA medicines and a proven track record of producing them at unprecedented speeds.”. “INOVIO’s CELLECTRA® intramuscular and intracellular smart devices have allowed us to deliver our optimized DNA plasmids directly into cells in the body to produce immune responses.Instagram:https://instagram. y mabs therapeuticscrypto trading classes near me5 year bond yieldbest real estate investment sites Shares Outstanding: As of September 30, 2023, INOVIO had 269.7 million common shares outstanding and 290.6 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible … insider trades trackingxle futures If you are thinking of buying or selling Inovio Pharmaceuticals stock, you should check out this FREE detailed report on its balance sheet.. A Different Perspective. While the broader market lost ...Inovio Pharmaceuticals. Market Cap. $137M. Today's Change. (-3.25%) -$0.02. Current Price. $0.51. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...Web et futures Inovio Pharmaceuticals saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 24,940,000 shares, a decline of 3.0% from the previous total of 25,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ...Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors from a year ago are still down 69%. (Simply Wall St.) Nov-18-22 11:42AM. Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs.